Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery

被引:113
作者
Jansen, Peter L. M. [1 ]
van Werven, Jochem [2 ]
Aarts, Edo [3 ]
Berends, Frits [3 ]
Janssen, Ignace [3 ]
Stoker, Jaap [2 ]
Schaap, Frank G. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastrointestinal & Liver Dis, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[3] Rijnstate Hosp, Dept Surg, Arnhem, Netherlands
关键词
Fibroblast growth factor 19; Fibroblast growth factor 21; Bile salts; Bariatric surgery; METABOLISM; OBESITY;
D O I
10.1159/000324128
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Thirty-five morbidly obese patients underwent Roux-en-Y gastric bypass surgery (RYGB). In addition to weight loss, these patients showed significant improvement of insulin resistance and a reduction of hepatic fat content. Three months after surgery, the serum bile salts were slightly but significantly elevated, and the levels of the endocrine-acting fibroblast growth factor 19 (FGF19) and FGF21 were increased. FGF19 and FGF21 play a role as regulators of hepatic lipid and glucose metabolism. These results show that RYGB surgery improves metabolism and that this improvement is still apparent 3 months after surgery. Bile salts may play a key role in the improvement of metabolism after RYGB. Why serum bile salt concentrations are elevated after RYGB needs to be investigated. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:48 / 51
页数:4
相关论文
共 10 条
[1]   Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis [J].
Bhatnagar, Sushant ;
Damron, Holly A. ;
Hillgartner, F. Bradley .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (15) :10023-10033
[2]   Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1α pathway [J].
Chau, Mary D. L. ;
Gao, Jiaping ;
Yang, Qing ;
Wu, Zhidan ;
Gromada, Jesper .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) :12553-12558
[3]   Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State [J].
Fisher, Ffolliott M. ;
Chui, Patricia C. ;
Antonellis, Patrick J. ;
Bina, Holly A. ;
Kharitonenkov, Alexei ;
Flier, Jeffrey S. ;
Maratos-Flier, Eleftheria .
DIABETES, 2010, 59 (11) :2781-2789
[4]   Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis [J].
Inagaki, T ;
Choi, M ;
Moschetta, A ;
Peng, L ;
Cummins, CL ;
McDonald, JG ;
Luo, G ;
Jones, SA ;
Goodwin, B ;
Richardson, JA ;
Gerard, RD ;
Repa, JJ ;
Mangelsdorf, DJ ;
Kliewer, SA .
CELL METABOLISM, 2005, 2 (04) :217-225
[5]   Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities [J].
Kohli, Rohit ;
Kirby, Michelle ;
Setchell, Kenneth D. R. ;
Jha, Pinky ;
Klustaitis, Kori ;
Woollett, Laura A. ;
Pfluger, Paul T. ;
Balistreri, William F. ;
Tso, Patrick ;
Jandacek, Ronald J. ;
Woods, Stephen C. ;
Heubi, James E. ;
Tschoep, Matthias H. ;
D'Alessio, David A. ;
Shroyer, Noah F. ;
Seeley, Randy J. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 299 (03) :G652-G660
[6]   Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes [J].
Laferrere, Blandine ;
Heshka, Stanley ;
Wang, Krystle ;
Khan, Yasmin ;
McGinty, James ;
Teixeira, Julo ;
Hart, Allison B. ;
Olivan, Blanca .
DIABETES CARE, 2007, 30 (07) :1709-1716
[7]   Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery [J].
Nakatani, Hiroshi ;
Kasama, Kazunori ;
Oshiro, Takashi ;
Watanabe, Mitsuhiro ;
Hirose, Hiroshi ;
Itoh, Hiroshi .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (10) :1400-1407
[8]   Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism [J].
Patti, Mary-Elizabeth ;
Houten, Sander M. ;
Bianco, Antonio C. ;
Bernier, Raquel ;
Larsen, P. Reed ;
Holst, Jens J. ;
Badman, Michael K. ;
Maratos-Flier, Eleftheria ;
Mun, Edward C. ;
Pihlajamaki, Jussi ;
Auwerx, Johan ;
Goldfine, Allison B. .
OBESITY, 2009, 17 (09) :1671-1677
[9]   The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance [J].
Schreuder, Tim C. M. A. ;
Marsman, Hendrik A. ;
Lenicek, Martin ;
van Werven, Jochem R. ;
Nederveen, Aart J. ;
Jansen, Peter L. M. ;
Schaap, Frank G. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 298 (03) :G440-G445
[10]   FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action [J].
Shin, Dong-Ju ;
Osborne, Timothy F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (17) :11110-11120